| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 63883-11-4 | 2,5-Cyclohexadiene-1,4-dione,2,5-dichloro-3,6-bis(1-naphthalenylamino)-; NSC 338075 |  | C26H16Cl2N2O2 | 詳情 | 供應(yīng)商 | |
| 57384-48-2 | 2H-3,1-Benzoxazine-2,4(1H)-dione,1-pentyl-; 1-Pentyl-1H-3,1-benzoxazine-2,4-dione; 1-Pentyl-1H-benzo[d][1,3]oxazine-2,4-dione |  | C13H15NO3 | 詳情 | 供應(yīng)商 | |
| 6331-24-4 | 2-Azabicyclo[3.3.1]nonane-1-aceticacid, 5-methyl-3-oxo-; NSC 47058 |  | C11H17NO3 | 詳情 | 供應(yīng)商 | |
| 17093-82-2 | 2-Propenoic acid,3-[4-(b-D-glucopyranosyloxy)-3-hydroxyphenyl]-; Cinnamicacid, 4-(b-D-glucopyranosyloxy)-3-hydroxy-(8CI); Cinnamic acid, 4-(b-D-glucosyloxy)-3-hydroxy- (6CI,7CI); Caffeic acid 4-O-b-D-glucopyranoside; Caffeic acid4-b-glucoside; Glucocaffeic acid; Glucosylcaffeic acid; NSC 115492 |  | C15H18O9 | 詳情 | 供應(yīng)商 | |
| 107659-61-0 | 2,3-Hexanediol,2-(4-chlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (2R,3S)-rel-; 2,3-Hexanediol,2-(4-chlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (R*,S*)- (9CI); 2,3-Hexanediol,2-(4-chlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, (R*,S*)-(?à)- |  | C14H18ClN3O2 | 詳情 | 供應(yīng)商 | |
| 120693-44-9 | 2H-1-Benzopyran-2-one,8-(hydroxymethyl)-5,7-dimethoxy-; MurrayacarpinB |  | C12H12O5 | 詳情 | 供應(yīng)商 | |
| 13277-41-3 | 2,2-Azetidinedicarboxylicacid, 3-chloro-4-oxo-1-phenyl-, 2,2-diethyl ester; 2,2-Azetidinedicarboxylicacid, 3-chloro-4-oxo-1-phenyl-, diethyl ester (8CI,9CI); NSC 117498 |  | C15H16ClNO5 | 詳情 | 供應(yīng)商 | |
| 108051-36-1 | 2-Propen-1-one,1-(2-hydroxy-5-iodophenyl)-3-(4-nitrophenyl)- |  | C15H10INO4 | 詳情 | 供應(yīng)商 | |
| 136581-65-2 | 2-Naphthalenol,decahydro-8a-methyl-4-methylene-6-(1-methylethenyl)-, (2S,4aS,6R,8aS)-; 2-Naphthalenol,decahydro-8a-methyl-4-methylene-6-(1-methylethenyl)-, [2S-(2a,4aa,6b,8ab)]-; Jatamol A |  | C15H24O | 詳情 | 供應(yīng)商 | |
| 148440-88-4 | 2,2'-Spirobi[4H-1,3-benzodioxin],dodecahydro- |  | C15H24O4 | 詳情 | 供應(yīng)商 | |
| 17294-92-7 | 2-Naphthalenol,1-ethyl-6-propyl-; 2-Naphthol,1-ethyl-6-propyl- (7CI,8CI) |  | C15H18O | 詳情 | 供應(yīng)商 | |
| 141554-22-5 | 2H-3,9a-Methano-1-benzoxepin-8,9-diol,octahydro-2,2,5a,9-tetramethyl-, (3R,5aR,8S,9R,9aR)-; 2H-3,9a-Methano-1-benzoxepin-8,9-diol,octahydro-2,2,5a,9-tetramethyl-, [3R-(3a,5aa,8b,9a,9aa)]-; Boariol |  | C15H26O3 | 詳情 | 供應(yīng)商 | |
| 145781-82-4 | 2-Propen-1-one,1-(2-hydroxyphenyl)-3-phenyl-, phenylhydrazone (9CI); RVC 574P |  | C21H18N2O | 詳情 | 供應(yīng)商 | |
| 16179-64-9 | 2-Cyclohexen-1-one,3-(cyclohexylamino)-; 3-Cyclohexylamino-2-cyclohexenone; NSC 264028 |  | C12H19NO | 詳情 | 供應(yīng)商 | |
| 110216-94-9 | 2(1H)-Quinolinone,1-methyl-4-[[(4-methylphenyl)sulfonyl]oxy]-3-(phenylmethyl)- |  | C24H21NO4S | 詳情 | 供應(yīng)商 | |
| 176546-55-7 | 2H-1-Benzopyran-2-one,4-(aminomethyl)-6,7-dihydroxy-; 2H-1-Benzopyran-2-one, 4-(aminomethyl)-6,7-dihydroxy- (9CI) |  | C10H9NO4 | 詳情 | 供應(yīng)商 | |
| 144333-78-8 | 2-Butenedioic acid(2Z)-, mono[(diphenylmethylene)hydrazide], magnesium salt (2:1) (9CI); 2-Butenedioicacid (Z)-, mono[(diphenylmethylene)hydrazide], magnesium salt (2:1) |  | C17H14N2O3.1/2Mg | 詳情 | 供應(yīng)商 | |
| 15517-26-7 | 2,4,6(1H,3H,5H)-Pyrimidinetrione,1-butyl-5,5-diethyl-; Barbituricacid, 1-butyl-5,5-diethyl- (8CI); N-Butylbarbital; N-n-Butylbarbital |  | C12H20N2O3 | 詳情 | 供應(yīng)商 | |
| 105072-18-2 | 2H-1-Benzopyran-7-ol,3,4-dihydro-3-(2-hydroxy-4-methoxyphenyl)-8-(3-methyl-2-butenyl)-, (S)- (9CI) |  | C21H24O4 | 詳情 | 供應(yīng)商 | |
| 107680-20-6 | 2,3-Butanediol,2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-imidazol-1-yl)-, (2R,3S)-rel-; 2,3-Butanediol,2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-imidazol-1-yl)-, (R*,S*)- (9CI); 2,3-Butanediol, 2-(4-chlorophenyl)-3-(4-fluorophenyl)-1-(1H-imidazol-1-yl)-,(R*,S*)-(?à)- |  | C19H18ClFN2O2 | 詳情 | 供應(yīng)商 | |